FARMINGTON HILLS, Mich., June 7, 2018 /PRNewswire-PRWeb/ -- E.M.M.A. International Consulting Group, Inc.(EMMA International)
EMMA International's Middle East and North Africa (MENA) expansion will be led by the MENA Regional Director, Joseph Yammine, a quality and regulatory expert with extensive experience working in the MENA region. Mr. Yammine will focus on growing the firm's presence and capability in the region.
EMMA International's MENA expansion will further enhance the firm's global presence and its position to serve the growing needs in the MENA region. By having a local Regional Director devoted to the needs of the region, clients will be able to access fully tailored services based on their needs and regulatory requirements. Some examples include:
"I am very excited about our new office expansion in Lebanon," said Dr. Carmine Jabri, President/CEO of EMMA International. "MENA is a region encompassing 22 countries and accounting for approximately 10% of the world's population, with an average increase of 3.5 % per year. Since the MENA owns around 60% of the world's oil reserves and 45% of the world's natural gas reserves, it is an important source of global economic stability."
To learn more about our services to the MENA region click here.
About EMMA International
E.M.M.A. International Consulting Group, Inc. is a global leader in management consulting services, with headquarters in Farmington Hills, MI, as well as offices in Florida and Pennsylvania. We focus on quality, regulatory, and compliance services for the biotechnology, pharmaceuticals, and medical device industries. EMMA International has services available to satisfy all your quality and compliance needs. We exclusively offer QualiPro, an EQMS, through our partnership with Saphir Consult.
SOURCE E.M.M.A. International Consulting Group, Inc.
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All